| Property | Expected finding | Observed | Conclusion, for or against XMRV/HMRV in humans? |
| | | +Hybridization array w. conserved viral 70-mers, an insensitive technique [9]. +Serendipitous. | For? | | Viral nucleic acid | +PCR (positive, XMRV [87], positive, HMRV [56] and −negative [3, 85, 88–100] results). −Proven or suspected contamination w 22Rv1-like virus and mouse DNA [3, 57, 93–96, 99–101]. | Against? | +Integration into host genome [8]. −Some of the integration sites occur in an XMRV-infected cell line [99]. | Against? | Discovery/followup | | +Cloning of XMRV into infectious clone (PC, ME/CFS) [8]. −High sequence similarity and unique recombination suggest contamination with DNA from XMRV producing cell line [2]. | Against? | | Virus isolation | +Virus isolation (ME/CFS patients) [6, 102, 103]. −High sequence similarity, lack of evolution, and unique recombination suggests contamination from XMRV producing cell line [2, 82]. −Isolation results cannot be reproduced [3]. | Against? | | Antiviral immune response | +SFFV FACS (ME/CFS) concordance with PCR outcome [6, 102], +ELISA (PC, ME/CFS), positive [104] and −negative [84, 92, 105–107] outcomes, −Virus neutralization, negative outcome [90], −Western blot (ME/CFS) negative outcome [105, 108], −CMIA (ME/CFS), negative outcome [109], −T-cell response, negative outcome [86]. | Against? |
| Epidemiology, early phase | Contact with mouse | Not observed/reported | Against? |
| Epidemiology, late phase | Human-human spread, via saliva, sex, and mother-child | −Although occasional ME/CFS outbreaks occur, most cases are sporadic, with no spread between spouses. −No reported epidemiological link between prostate cancer and ME/CFS −No known overrepresentation in STD and in IVDU [85]. | Against? |
| Pathogenesis | Leukemia, lymphoma | Prostate cancer? | For or against? | Immunodeficiency | Immunodeficiency? | Encephalitis (MAIDS) | Myalgic encephalomyelitis? | Enteritis (MAIDS, FAIDS) | Irritable bowel syndrome? | Autoimmunity | Thyroiditis? |
| Replication | Relatively easy to detect in blood | Hard to detect in blood. | Against? |
| Immune response | Strong B-cell response, positive WB | Weak or absent B-cell response. | Against? |
|
|